CD4 and neoplasm: Flow cytometry analyses of cells isolated from CT26 tumors on day 13 indicated that 45 ± 3% of the CD4+ TILs were Tregs (FOXP3+), and 54 ± 2% of the tumor-infiltrating Tregs expressed GARP, regardless of the treatment (Supplementary Fig. 5a).